Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$218,310
New position
Shares Held
1,393
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,280
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First National Trust Co holds $128,309,128 across 8 Drug Manufacturers - General names. NVS ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,798 | $36,940,047 | |
| 2 | JNJ |
Johnson & Johnson
|
125,659 | $31,913,616 | |
| 3 | MRK |
Merck & Co., Inc.
|
179,140 | $23,019,489 | |
| 4 | ABBV |
AbbVie Inc.
|
74,068 | $18,638,470 | |
| 5 | AMGN |
Amgen Inc
|
42,011 | $15,213,022 | |
| 6 | PFE |
Pfizer Inc
|
52,136 | $1,255,434 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,277 | $1,110,740 | |
| 8 | NVS |
Novartis AG
This page
|
1,393 | $218,310 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $218,310 | 1,393 | Shares | Sole | 2026-07-30 | |
| No filing history on record for this holder in this stock. | ||||||